Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14 clinical trials
None
Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura

The following study is being conducted to explore the safety and effectiveness of a new chemical entity called NXN-188 in subjects with a history of migraine with aura. In this study

numbness
implanon
headache
dysphasia
hysterectomy
  • 8 views
  • 07 Nov, 2020
  • 1 location
None
Study of Sumatriptan Naproxen Sodium Succinate Tablets for the Treatment of Acute Migraine Attacks

A multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of sumatriptan naproxen sodium succinate tablets in the treatment of acute migraine attacks.

  • 0 views
  • 15 Jul, 2021
  • 1 location
None
Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache

: Headaches are a common complaint presenting to the emergency department (ED), accounting for 1-2% of all ED visits, with migraines as the second most common primary headache syndrome. Patients that ultimately present to the ED have failed outpatient therapy and exhibit severe and persistent symptoms. Treatment options have been …

dihydroergotamine
headache
sumatriptan
metoclopramide
nausea
  • 286 views
  • 07 Nov, 2020
  • 1 location
None
A Randomized Double-Blind Parallel Group Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine

Study STS101-007 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101 (dihydroergotamine nasal powder) in the acute treatment of migraine.

dihydroergotamine
acute treatment
headache
  • 5 views
  • 09 Nov, 2021
  • 144 locations
None
Digital Treatment for Migraines - a Feasibility Study

An individualised internet-based treatment from a biopsychosocial perspective for patients with migraines in primary care has been developed within the Vastra Gotaland region in 2019. The treatment program is called Learning to live with migraines, and goes by the acronym "I am" (Internet Approach to Migraine). In a pilot study, …

  • 0 views
  • 01 Sep, 2021
  • 1 location
None
Transnasal Cooling for Migraine

This is a prospective, double-blind, sham-controlled, randomized study to assess the safety, tolerability, and optimal dose of the COOLSTAT Transnasal Thermal Regulating Device for acute treatment of migraine. The hypothesis is that evaporative cooling induced by the CoolStat using only ambient, dry air will reduce the pain and other symptoms …

headache
migraine prophylaxis
acute migraine
hemiplegic migraine
  • 0 views
  • 14 Nov, 2021
  • 2 locations
None
Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura

To investigate the migraine inducing effect of levcromakalim in patients with migraine with aura.

migraine with aura
  • 0 views
  • 20 Oct, 2021
  • 1 location
None
Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room

The purpose of this study is to evaluate the efficacy of clorazepate in addition to the usual medication for treating migraine attack in the emergency room

headache
metoclopramide
ketoprofen
migraine
  • 0 views
  • 23 Jul, 2021
  • 1 location
None
A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine

Study STS101-003 is a multi-center, multiple dose (PRN), open-label, 12-month study to evaluate the safety and tolerability of STS101 (dihydroergotamine nasal powder) in the acute treatment of migraine.

dihydroergotamine
acute treatment
headache
  • 311 views
  • 16 Nov, 2021
  • 48 locations
None
The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients

A randomized, double-blind, placebo-controlled, parallel study to investigate the effect of erenumab in calcitonin-gene related peptide and cilostazol experimental models of migraine in humans. Followed by a 6-month open-label extension.

calcitonin gene-related peptide
headache
calcitonin
erenumab
cilostazol
  • 22 views
  • 26 Jan, 2021
  • 1 location